A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
The future of life sciences is hurtling towards a digital revolution with emphasis on immediacy for the pharmaceutical, biopharmaceutical, and medical device technology value chain.
The power of RWD and RWE continues to play a key role in helping increase research efficiency and accelerate the introduction of new treatments.
More and more researchers are turning to actionable insights derived from the PINC AI™ Healthcare Database to further knowledge about cancer.
Premier's Karen Niven highlights the essential role of change management in successful healthcare value analysis programs.
bioMérieux and PINC AI™ Applied Sciences collaborate to understand the epidemiology, HRU and costs related to AGE in adult patients.
Partnering with PINC AI™ Stanson’s clinical decision support (CDS) technology platform empowered a large health system in Missouri to significantly improve HCC coding accuracy.
Premier’s Chief Pharmacy Officer Jessica Daley joins a panel of experts to discuss strategies to manage and mitigate drug shortages.
To remain competitive, health systems must design a consumer-centric care delivery model that’s tech-enabled and focused on access to care, convenience and patient-defined outcomes.
HFMA |
In this Executive Roundtable sponsored by Remitra®, participants discussed ways to relieve labor cost increases, inflation, declining Medicare reimbursements and clawbacks.
See the highlights from the grand opening event for a new Premier-led joint venture established to manufacture vital healthcare products in Norfolk, VA.
Actionable Insights |
Premier's David Hargraves discusses the current and future state of the healthcare supply chain as we emerge from the global pandemic.
By Susan Gullo, Director, Women and Infants Service Line, Premier Inc.